Whole-genome sequencing of liver cancers identifies etiological influences on mutation patterns and recurrent mutations in chromatin regulators - PubMed (original) (raw)
. 2012 May 27;44(7):760-4.
doi: 10.1038/ng.2291.
Yasushi Totoki, Tetsuo Abe, Keith A Boroevich, Fumie Hosoda, Ha Hai Nguyen, Masayuki Aoki, Naoya Hosono, Michiaki Kubo, Fuyuki Miya, Yasuhito Arai, Hiroyuki Takahashi, Takuya Shirakihara, Masao Nagasaki, Tetsuo Shibuya, Kaoru Nakano, Kumiko Watanabe-Makino, Hiroko Tanaka, Hiromi Nakamura, Jun Kusuda, Hidenori Ojima, Kazuaki Shimada, Takuji Okusaka, Masaki Ueno, Yoshinobu Shigekawa, Yoshiiku Kawakami, Koji Arihiro, Hideki Ohdan, Kunihito Gotoh, Osamu Ishikawa, Shun-Ichi Ariizumi, Masakazu Yamamoto, Terumasa Yamada, Kazuaki Chayama, Tomoo Kosuge, Hiroki Yamaue, Naoyuki Kamatani, Satoru Miyano, Hitoshi Nakagama, Yusuke Nakamura, Tatsuhiko Tsunoda, Tatsuhiro Shibata, Hidewaki Nakagawa
Affiliations
- PMID: 22634756
- DOI: 10.1038/ng.2291
Whole-genome sequencing of liver cancers identifies etiological influences on mutation patterns and recurrent mutations in chromatin regulators
Akihiro Fujimoto et al. Nat Genet. 2012.
Abstract
Hepatocellular carcinoma (HCC) is the third leading cause of cancer-related death worldwide. We sequenced and analyzed the whole genomes of 27 HCCs, 25 of which were associated with hepatitis B or C virus infections, including two sets of multicentric tumors. Although no common somatic mutations were identified in the multicentric tumor pairs, their whole-genome substitution patterns were similar, suggesting that these tumors developed from independent mutations, although their shared etiological backgrounds may have strongly influenced their somatic mutation patterns. Statistical and functional analyses yielded a list of recurrently mutated genes. Multiple chromatin regulators, including ARID1A, ARID1B, ARID2, MLL and MLL3, were mutated in ∼50% of the tumors. Hepatitis B virus genome integration in the TERT locus was frequently observed in a high clonal proportion. Our whole-genome sequencing analysis of HCCs identified the influence of etiological background on somatic mutation patterns and subsequent carcinogenesis, as well as recurrent mutations in chromatin regulators in HCCs.
Comment in
- Next generation sequencing of HCC from European and Asian HCC cohorts. Back to p53 and Wnt/β-catenin.
Teufel A, Marquardt JU, Galle PR. Teufel A, et al. J Hepatol. 2013 Mar;58(3):622-4. doi: 10.1016/j.jhep.2012.10.006. Epub 2012 Oct 11. J Hepatol. 2013. PMID: 23063568 No abstract available.
Similar articles
- Comprehensive analyses of mutations and hepatitis B virus integration in hepatocellular carcinoma with clinicopathological features.
Kawai-Kitahata F, Asahina Y, Tanaka S, Kakinuma S, Murakawa M, Nitta S, Watanabe T, Otani S, Taniguchi M, Goto F, Nagata H, Kaneko S, Tasaka-Fujita M, Nishimura-Sakurai Y, Azuma S, Itsui Y, Nakagawa M, Tanabe M, Takano S, Fukasawa M, Sakamoto M, Maekawa S, Enomoto N, Watanabe M. Kawai-Kitahata F, et al. J Gastroenterol. 2016 May;51(5):473-86. doi: 10.1007/s00535-015-1126-4. Epub 2015 Nov 9. J Gastroenterol. 2016. PMID: 26553052 - Distinct Patterns of HBV Integration and TERT Alterations between in Tumor and Non-Tumor Tissue in Patients with Hepatocellular Carcinoma.
Jang JW, Kim HS, Kim JS, Lee SK, Han JW, Sung PS, Bae SH, Choi JY, Yoon SK, Han DJ, Kim TM, Roberts LR. Jang JW, et al. Int J Mol Sci. 2021 Jun 30;22(13):7056. doi: 10.3390/ijms22137056. Int J Mol Sci. 2021. PMID: 34209079 Free PMC article. - Telomerase reverse transcriptase promoter mutations in hepatitis B virus-associated hepatocellular carcinoma.
Yang X, Guo X, Chen Y, Chen G, Ma Y, Huang K, Zhang Y, Zhao Q, Winkler CA, An P, Lyu J. Yang X, et al. Oncotarget. 2016 May 10;7(19):27838-47. doi: 10.18632/oncotarget.8539. Oncotarget. 2016. PMID: 27056898 Free PMC article. - Comprehensive genome sequencing of the liver cancer genome.
Nakagawa H, Shibata T. Nakagawa H, et al. Cancer Lett. 2013 Nov 1;340(2):234-40. doi: 10.1016/j.canlet.2012.10.035. Epub 2012 Nov 8. Cancer Lett. 2013. PMID: 23142287 Review. - Mutations in TP53, CTNNB1 and PIK3CA genes in hepatocellular carcinoma associated with hepatitis B and hepatitis C virus infections.
Tornesello ML, Buonaguro L, Tatangelo F, Botti G, Izzo F, Buonaguro FM. Tornesello ML, et al. Genomics. 2013 Aug;102(2):74-83. doi: 10.1016/j.ygeno.2013.04.001. Epub 2013 Apr 11. Genomics. 2013. PMID: 23583669 Review.
Cited by
- USP26 as a hepatitis B virus-induced deubiquitinase primes hepatocellular carcinogenesis by epigenetic remodeling.
Ma M, Yi L, Pei Y, Zhang Q, Tong C, Zhao M, Chen Y, Zhu J, Zhang W, Yao F, Yang P, Zhang P. Ma M, et al. Nat Commun. 2024 Sep 9;15(1):7856. doi: 10.1038/s41467-024-52201-z. Nat Commun. 2024. PMID: 39251623 Free PMC article. - SOX11 as a potential prognostic biomarker in hepatocellular carcinoma linked to immune infiltration and ferroptosis.
Chen H, Ao Q, Wang Y, Qian Y, Cheng Q, Zhang W. Chen H, et al. Chin J Cancer Res. 2024 Aug 30;36(4):378-397. doi: 10.21147/j.issn.1000-9604.2024.04.03. Chin J Cancer Res. 2024. PMID: 39246708 Free PMC article. - The modification role and tumor association with a methyltransferase: KMT2C.
Jiao Y, Lv Y, Liu M, Liu Y, Han M, Xiong X, Zhou H, Zhong J, Kang X, Su W. Jiao Y, et al. Front Immunol. 2024 Aug 6;15:1444923. doi: 10.3389/fimmu.2024.1444923. eCollection 2024. Front Immunol. 2024. PMID: 39165358 Free PMC article. Review. - Multiple asynchronous recurrence as a predictive factor for refractoriness against locoregional and surgical therapy in patients with intermediate-stage hepatocellular carcinoma.
Kasuga R, Taniki N, Chu PS, Tamura M, Tabuchi T, Yamaguchi A, Hayatsu S, Koizumi J, Ojiro K, Hoshi H, Kaneko F, Morikawa R, Noguchi F, Yamataka K, Usui S, Ebinuma H, Itano O, Hasegawa Y, Abe Y, Kitago M, Inoue M, Nakatsuka S, Jinzaki M, Kitagawa Y, Kanai T, Nakamoto N. Kasuga R, et al. Sci Rep. 2024 May 13;14(1):10896. doi: 10.1038/s41598-024-61611-4. Sci Rep. 2024. PMID: 38740983 Free PMC article. - Unmet needs in the post-direct-acting antivirals era: The risk and molecular mechanisms of hepatocellular carcinoma after hepatitis C virus eradication.
Huang CF, Awad MH, Gal-Tanamy M, Yu ML. Huang CF, et al. Clin Mol Hepatol. 2024 Jul;30(3):326-344. doi: 10.3350/cmh.2024.0155. Epub 2024 Apr 26. Clin Mol Hepatol. 2024. PMID: 38665034 Free PMC article. Review.
References
- N Engl J Med. 1981 Oct 29;305(18):1067-73 - PubMed
- Proc Natl Acad Sci U S A. 2009 Jul 14;106(28):11667-72 - PubMed
- Genome Res. 2012 Apr;22(4):593-601 - PubMed
- Nat Med. 2006 May;12(5):568-73 - PubMed
- Hepatology. 2010 Apr;51(4):1383-90 - PubMed
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical